ArticlesAbstractPharmacognosy Research,2024,16,3,558-569.DOI:10.5530/pres.16.3.66Published:June 2024Type:Original ArticleAuthors:Dinesh Vasava, Poonam Bhagriya Abhishek Tote, and Keyur Sindhava Nitin Solanki Author(s) affiliations:Dinesh Vasava*, Poonam Bhagriya, Abhishek Tote, Keyur Sindhava, Nitin Solanki Department of Biosciences, Sardar Patel University, Sardar Patel Maidan, Vallabh Vidyanagar, Gujarat, INDIA. Abstract:Objectives: This study investigates the in vitro efficient pathway for the callus induction from nodal explant and isolation of the Shatavarin-IV from the callus extract from fresh callus and Dry callus. The effect of Shatavarin IV was examined on the Human lung carcinoma cell line. Gene expression study was carried out using a specific primer to conform weather it is anticancer compound or not. Materials and Methods: In the present study, 2,4-D and Kn were used for the direct callus induction. Callus culture, organogenesis and cell culture are used to harvest secondary metabolites. Quantification of Shatavarin-IV was performed using a TLC scanner at a wavelength of 425 nm. HPTLC analysis was performed to quantitatively determine the presence of Shatavarin-IV in Fresh Callus (FC), Dry Callus (DC) and Root Extract (RE). The mobile phase used for HPTLC analysis was ethyl acetate: methanol: water: formic acid (7.5:1.5:1:0.2 v/v). Extraction was carried out using 80% methanol and the extract was filtered. The extract was then analyzed using HPTLC methods. Further, the effect of Shatavarin-IV was studied on the human lung carcinoma cell line NCI-H23. The end result of cell cytotoxicity was analyzed using MTT dye. To, confirm whether the cell expressed an apoptotic gene or not RTPCR studies were been carried out. Results: The best hormonal combination for callus induction from nodal explant was found 11.31 μM 2,4-D combined with 4.64 μM Kn on MS as basal media. Shatavarin-IV accumulation in dry callus was 0.0305% w/w, wild-grown plant root extract showed 0.01732% w/w and in fresh callus presence of Shatavarin-IV was 0.0012% w/w. IC50 of the Shatavarin-IV was 0.8 Micromolar dissolved in DMSO. Gene expression study reflects the multifold increase of the BAX and decrease of BCL2, concluded interpreted as Shatavarin-IV causes apoptotic gene expression. Conclusion: It was concluded that, Shatavarin IV reduced the expression of BCL2 and increase BAX expression which positive sign that Shatavarin IV act as an anticancer compound. Shatavarin IV can be isolated from the in vitro callus culture, which can be alternative of whole plant that was exploited for its medicinal properties. (Schematic Abstract). Keywords:Antiproliferative, Dry Callus, Fresh Callus, Gene expression, Phylloclade, Shatavarin-IVView:PDF (914.25 KB) PDF Thumbnails Document Outline Search Document Find Toggle Sidebar Previous Next Page: Fullscreen Print Download Current View Zoom Out Zoom In Automatic Zoom Actual Size Fit Page Full Width 50% 75% 100% 125% 150% 200% More Information Less Information Close Click here to download the PDF file. Images Gene expression fold change after 24 hr of Shatavarin-IV treatment to NCI-H23 cell line.Fold change in gene expression was analysed using qPCR. Gene expression of BAX,BCL2 and E.CAD was normalised to β-Actin.Statistical analyses were performed on the data.Values represent the Mean±SEM. (p ≤ 0.0001).Fold change in gene expression in comparison to untreated (U.T.) NCI-H23 cells. KeywordsAntiproliferativeDry CallusFresh CallusGene expressionPhyllocladeShatavarin-IV ‹ Exploring the Logic Behind the Usage of Fresh Drugs in Ayurvedic Formulations through Preliminary Phytochemistry and HPTLC Analysis up Identification of Bioactive Ingredients of Traditional Medicinal Plants Psiadia arabica Jaub. Tamarix articulata, Terminalia arjuna and Rhazya stricta by GC-MS in Saudi Arabia ›